CRVO logo

CervoMed Inc.

CRVO
Healthcare|Biotechnology|US
$1.42
-0.03 (-2.07%)
DCF Value
$0.80
Tangible Book / Share
$1.15
Cash / Share
$1.30
Next Earnings Report
Mar 12, 2027
EPS est. -$0.64 · Revenue est. $83.3K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Jul 10, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Sep 2026
P2
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
NCT07033481

Recent Press Releases

CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)
Oct 29, 2026 · GlobeNewsWire
CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit
Sep 28, 2026 · GlobeNewsWire
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Sep 22, 2026 · GlobeNewsWire
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026
Sep 10, 2026 · GlobeNewsWire
CervoMed to Participate in September Investor Conferences
Sep 8, 2026 · GlobeNewsWire
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Aug 10, 2026 · GlobeNewsWire

SEC Filings (84)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Oct 29, 20268-KMaterial eventDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Oct 13, 20268-KMaterial eventDocumentIndex
Oct 9, 20268-KMaterial eventDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Sep 10, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Aug 7, 2026S-8Employee stock planDocumentIndex
Aug 7, 202610-QQuarterly reportDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 14, 20268-KMaterial eventDocumentIndex
Jul 10, 2026EFFECTDocumentIndex
Jul 10, 2026424B3Offering prospectusDocumentIndex
Jul 9, 20268-KMaterial eventDocumentIndex
Jul 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 6, 2026S-3Shelf registrationDocumentIndex
Jun 26, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 22, 20268-KMaterial eventDocumentIndex
Jun 22, 2026424B5Offering prospectusDocumentIndex
Jun 22, 20268-KMaterial eventDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
Jun 15, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 15, 20268-KMaterial eventDocumentIndex
Jun 10, 20268-KMaterial eventDocumentIndex
Jun 9, 20268-KMaterial eventDocumentIndex
May 18, 20268-KMaterial eventDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 22, 20268-KMaterial eventDocumentIndex
Apr 7, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 7, 20268-KMaterial eventDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex